Trial Profile
The efficacy and tolerability of adjunctive retigabine in adult patients with refractory partial onset epilepsy in Slovakia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Apr 2014
Price :
$35
*
At a glance
- Drugs Retigabine (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 29 Apr 2014 New trial record